NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Trade Payables History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Trade Payables | ₹275 Cr | ₹236 Cr | ₹264 Cr | ₹162 Cr | ₹146 Cr |
What is the latest Trade Payables ratio of NATCO PHARMA ?
| Year | Trade Payables |
|---|---|
| Mar2025 | ₹275 Cr |
| Mar2024 | ₹236 Cr |
| Mar2023 | ₹264 Cr |
| Mar2022 | ₹162 Cr |
| Mar2021 | ₹146 Cr |
How is Trade Payables of NATCO PHARMA Trending?
| Years | Trade Payables | % Change | |
|---|---|---|---|
| Mar2025 | ₹275 Cr | 16.73 | |
| Mar2024 | ₹236 Cr | -10.73 | |
| Mar2023 | ₹264 Cr | 63.04 | |
| Mar2022 | ₹162 Cr | 10.67 | |
| Mar2021 | ₹146 Cr | - | |
Compare Trade Payables of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,841.4 Cr | 4% | 4.7% | -28.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,062.0 Cr | 0.4% | 2.6% | NA | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,192.0 Cr | -4.5% | 0.7% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,129.0 Cr | 5% | 4.1% | 37.2% | Stock Analytics | |
| CIPLA | ₹108,513.0 Cr | -0.5% | -3.4% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,250.0 Cr | 1.2% | 10.2% | 4.8% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 4% |
4.7% |
-28.9% |
| SENSEX | -1% |
-0.1% |
7.9% |
You may also like the below Video Courses